Sangamo Therapeutics (SGMOQ) Asset Utilization Ratio (2011 - 2025)
Sangamo Therapeutics (SGMOQ) posted quarterly Asset Utilization Ratio of 0.53 for Q4 2025, little changed year-over-year from 0.53 in Q4 2024, and up 55.95% quarter-over-quarter from 0.34 in Q3 2025.
Sangamo Therapeutics (SGMOQ) Asset Utilization Ratio (2011 - 2025) Analysis & Trends
Sangamo Therapeutics' Asset Utilization Ratio history runs 15 years deep, the most recent figure standing at 0.53 for Q4 2025.
- In Q4 2025, Asset Utilization Ratio changed 0.0% year-over-year to 0.53; the TTM figure through Dec 2025 stood at 0.53 (changed 0.0% YoY), while the FY2025 annual figure was 0.49, up 13.2% from the prior year.
- Asset Utilization Ratio for Q4 2025 stood at 0.53, up from 0.34 in the prior quarter.
- The five-year high for Asset Utilization Ratio was 0.92 in Q4 2023, with the low at 0.11 in Q2 2024.
- The 5-year median for Asset Utilization Ratio is 0.27 (2022), against an average of 0.39.
- The sharpest annual moves came in 2024 and 2025: Asset Utilization Ratio slumped 80.62% in 2024, then surged 693.74% in 2025.
- Sangamo Therapeutics' Asset Utilization Ratio stood at 0.15 in 2021, then increased by 29.92% to 0.19 in 2022, then surged by 375.59% to 0.92 in 2023, then slumped by 41.77% to 0.53 in 2024, then declined by 0.0% to 0.53 in 2025.
- Business Quant data shows SGMOQ's Asset Utilization Ratio at 0.53 in Q4 2025, 0.34 in Q3 2025, and 0.88 in Q2 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.53 |
| Sep 30, 2025 | 0.34 |
| Jun 30, 2025 | 0.88 |
| Mar 31, 2025 | 0.67 |
| Dec 31, 2024 | 0.53 |
| Sep 30, 2024 | 0.51 |
| Jun 30, 2024 | 0.11 |
| Mar 31, 2024 | 0.13 |
| Dec 31, 2023 | 0.92 |
| Sep 30, 2023 | 0.74 |
| Jun 30, 2023 | 0.57 |
| Mar 31, 2023 | 0.48 |
| Dec 31, 2022 | 0.19 |
| Sep 30, 2022 | 0.19 |
| Jun 30, 2022 | 0.18 |
| Mar 31, 2022 | 0.16 |
| Dec 31, 2021 | 0.15 |
| Sep 30, 2021 | 0.13 |
| Jun 30, 2021 | 0.16 |
| Mar 31, 2021 | 0.14 |